DNTOX

About:

an in vitro testing battery for safe chemicals

Website: https://dntox.de

Top Investors: HTGF | High-Tech Gruenderfonds, AQAL Integral Investing, Bool Capital, Barbara Korte-Sturm, Nikolaus Sturm

Description:

We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, it is supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!

Total Funding Amount:

1.4M EUR

Headquarters Location:

Düsseldorf, Nordrhein-Westfalen, Germany

Founded Date:

2022-01-01

Founders:

Arif Dönmez, Axel Mosig, Ellen Fritsche, Katharina Koch, Kristina Bartmann, Silke Beaucamp

Number of Employees:

1-10

Last Funding Date:

2023-06-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai